Rasbase 1.5mg Injection

About

Rasbase 1.5mg Injection is a highly selective 5-hydroxytryptamine-3 (5-HT3) receptor antagonist, specifically designed to prevent and treat nausea and vomiting. Its mechanism of action involves blocking serotonin's ability to bind to 5-HT3 receptors, which are located both peripherally on vagal nerve terminals in the gastrointestinal tract and centrally in the chemoreceptor trigger zone (CTZ) of the brain. By inhibiting these receptors, Rasbase effectively interrupts the neural pathways that initiate the emetic reflex. This medication is particularly valuable in clinical settings for managing chemotherapy-induced nausea and vomiting (CINV), which can be highly debilitating for cancer patients, as well as for preventing post-operative nausea and vomiting (PONV). Its rapid onset and prolonged duration of action provide effective control over emetic episodes, significantly enhancing patient comfort and compliance with ongoing medical treatments.

Uses

• Prevention of chemotherapy-induced nausea and vomiting
• Prevention of radiation-induced nausea and vomiting
• Prevention of post-operative nausea and vomiting
• Management of acute emesis

Directions For Use

Administered intravenously by a healthcare professional, typically before chemotherapy or surgery. Follow your doctor's instructions precisely.

Benefits

• Highly effective in preventing nausea
• Significantly reduces vomiting episodes
• Improves patient comfort during treatment
• Allows for better tolerance of chemotherapy
• Rapid onset of action
• Long duration of antiemetic effect

Side Effects

• Headache
• Constipation
• Asthenia (weakness)
• Diarrhea
• Dizziness
• Insomnia
• Abdominal pain
• Dyspepsia
• Injection site reactions
• QT prolongation (rare)
• Hypersensitivity reactions (rare)
• Bradycardia (rare)

Safety Measures

• Alcohol - No direct interaction, but alcohol can exacerbate nausea and vomiting, counteracting the medication's effect.
• Pregnancy - Use only if clearly needed; limited data available, potential risks not fully established. Consult your doctor.
• Breastfeeding - Unknown if excreted in human milk; caution advised, weigh benefits vs. risks with your doctor.
• Liver - No specific dose adjustment needed for mild to moderate hepatic impairment.
• Kidney - No specific dose adjustment needed for renal impairment.
• Lung - No specific lung-related precautions, but monitor for hypersensitivity reactions which can affect respiratory function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.